Gary S. Stetz, Interim CEO at Hepion Pharmaceuticals, Inc. (HEPA), bought 2,000,000 shares at $0.05 ($100K) on 2026-08-03, disclosed to the SEC on 2026-08-12.
Interim CEO Gary S. Stetz purchased $100,000 of stock at $0.05, marking the largest insider purchase in the company's history and a rare reversal after a period of selling. This high-profile buy by C-suite leadership suggests the CEO believes the stock is undervalued at current levels.
HEPA is currently trading at $0.3181, which is 3% above its 52-week low of $0.318 but flat over the last 30 and 90 days.
Insider cluster momentum: Three other insiders bought shares in the last 30 days; track this momentum.
Short interest: The stock has a short interest of 4.1% of the float, indicating significant bearish sentiment.
Something here stands out, but not much.
| Filing → |
| HEPA | BUY | 2026-04-27 | $50K | — | Filing → |
| BCBP | BUY | 2018-03-14 | $8K | — | Filing → |
| BCBP | BUY | 2017-10-25 | $26K | — | Filing → |